AP
ALDR

AlpInvest Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

AlpInvest Partners’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,913
Closed -$316K – 34
2016
Q1 		$316K Sell
12,913
-4,300
-25% -$99.6K 0.6% 24
2015
Q4 		$569K Hold
17,213
– – 0.95% 19
2015
Q3 		$564K Buy
+17,213
New +$732K 1.11% 24

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AlpInvest Partners's ALDR Position: Q2 2016 in Review

AlpInvest Partners sold out of Alder Biopharmaceuticals (ALDR) in Q2 2016, closing a stake of 12,913 shares — an estimated $316K sold.

AlpInvest Partners first reported a position in ALDR in Q3 2015 and held it in 3 quarters. The position peaked at $569K in Q4 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q2 2016.

  • AlpInvest Partners reported no remaining Alder Biopharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • AlpInvest Partners sold 12,913 Alder Biopharmaceuticals shares in Q2 2016, an estimated $316K.
  • AlpInvest Partners first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 3 quarters.
  • AlpInvest Partners's Alder Biopharmaceuticals position peaked at $569K in Q4 2015.
  • 145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2016.

Based on AlpInvest Partners's 13F filing for Q2 2016, filed 10 Aug 2016.